Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease
Identifieur interne : 001300 ( Main/Exploration ); précédent : 001299; suivant : 001301Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease
Auteurs : Elina Tripoliti [Royaume-Uni] ; Laura Strong [Royaume-Uni] ; Freya Hickey [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-11.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Deep Brain Stimulation (adverse effects), Deep brain stimulation, Dysarthria, Dysarthria (etiology), Dysarthria (physiopathology), Dysarthria (therapy), Humans, LSVT, Middle Aged, Nervous system diseases, Parkinson Disease (therapy), Parkinson disease, Parkinson's disease, STN‐DBS, Severity of Illness Index, Speech, Speech Therapy (methods), Subthalamic Nucleus (physiology), Subthalamic Nucleus (surgery), Subthalamic nucleus, Treatment, Treatment Outcome, speech.
- MESH :
- adverse effects : Deep Brain Stimulation.
- etiology : Dysarthria.
- methods : Speech Therapy.
- physiology : Subthalamic Nucleus.
- physiopathology : Dysarthria.
- surgery : Subthalamic Nucleus.
- therapy : Dysarthria, Parkinson Disease.
- Humans, Middle Aged, Severity of Illness Index, Treatment Outcome.
Abstract
Background:: Deep brain stimulation of the subthalamic nucleus (STN‐DBS) is an established treatment for patients with Parkinson's disease (PD). Speech impairment is a frequent side effect of the surgery. This study examined the efficacy of an intensive speech treatment, the Lee Silverman Voice Treatment (LSVT) on dysarthria after STN‐DBS. Methods:: The LSVT was administered to 10 patients with STN‐DBS (surgical group) and 10 patients without (medical group). Patients were assessed before, immediately after, and 6 months following the speech treatment using sustained phonation, a speech intelligibility scale, and monologue. Vocal loudness, speech intelligibility, and perceptual ratings were the primary outcome measures. Results:: Vocal loudness and perceptual scores improved significantly across tasks for the medical group only. Speech intelligibility did not significantly change for either group. Results in the surgical group were variable, with some patients deteriorating. Conclusions:: Treatment of dysarthria following STN‐DBS needs further investigation because of the variable response to LSVT. © 2011 Movement Disorder Society
Url:
- https://api.istex.fr/document/12A5E4E8257155C2B556028FF95ECCC9859A26B3/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223328
DOI: 10.1002/mds.23887
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C51
- to stream Istex, to step Curation: 000C51
- to stream Istex, to step Checkpoint: 000032
- to stream Pmc, to step Corpus: 000184
- to stream Pmc, to step Curation: 000184
- to stream Pmc, to step Checkpoint: 000220
- to stream PubMed, to step Corpus: 001033
- to stream PubMed, to step Curation: 001033
- to stream PubMed, to step Checkpoint: 001016
- to stream Ncbi, to step Merge: 003397
- to stream Ncbi, to step Curation: 003397
- to stream Ncbi, to step Checkpoint: 003397
- to stream Main, to step Merge: 001353
- to stream PascalFrancis, to step Corpus: 000338
- to stream PascalFrancis, to step Curation: 002976
- to stream PascalFrancis, to step Checkpoint: 000342
- to stream Main, to step Merge: 001932
- to stream Main, to step Curation: 001300
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease</title><author><name sortKey="Tripoliti, Elina" sort="Tripoliti, Elina" uniqKey="Tripoliti E" first="Elina" last="Tripoliti">Elina Tripoliti</name></author><author><name sortKey="Strong, Laura" sort="Strong, Laura" uniqKey="Strong L" first="Laura" last="Strong">Laura Strong</name></author><author><name sortKey="Hickey, Freya" sort="Hickey, Freya" uniqKey="Hickey F" first="Freya" last="Hickey">Freya Hickey</name></author><author><name sortKey="Foltynie, Tom" sort="Foltynie, Tom" uniqKey="Foltynie T" first="Tom" last="Foltynie">Tom Foltynie</name></author><author><name sortKey="Zrinzo, Ludvic" sort="Zrinzo, Ludvic" uniqKey="Zrinzo L" first="Ludvic" last="Zrinzo">Ludvic Zrinzo</name></author><author><name sortKey="Candelario, Joseph" sort="Candelario, Joseph" uniqKey="Candelario J" first="Joseph" last="Candelario">Joseph Candelario</name></author><author><name sortKey="Hariz, Marwan" sort="Hariz, Marwan" uniqKey="Hariz M" first="Marwan" last="Hariz">Marwan Hariz</name></author><author><name sortKey="Limousin, Patricia" sort="Limousin, Patricia" uniqKey="Limousin P" first="Patricia" last="Limousin">Patricia Limousin</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:12A5E4E8257155C2B556028FF95ECCC9859A26B3</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23887</idno><idno type="url">https://api.istex.fr/document/12A5E4E8257155C2B556028FF95ECCC9859A26B3/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000C51</idno><idno type="wicri:Area/Istex/Curation">000C51</idno><idno type="wicri:Area/Istex/Checkpoint">000032</idno><idno type="wicri:doubleKey">0885-3185:2011:Tripoliti E:treatment:of:dysarthria</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223328</idno><idno type="RBID">PMC:3223328</idno><idno type="wicri:Area/Pmc/Corpus">000184</idno><idno type="wicri:Area/Pmc/Curation">000184</idno><idno type="wicri:Area/Pmc/Checkpoint">000220</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">001033</idno><idno type="wicri:Area/PubMed/Curation">001033</idno><idno type="wicri:Area/PubMed/Checkpoint">001016</idno><idno type="wicri:Area/Ncbi/Merge">003397</idno><idno type="wicri:Area/Ncbi/Curation">003397</idno><idno type="wicri:Area/Ncbi/Checkpoint">003397</idno><idno type="wicri:doubleKey">0885-3185:2011:Tripoliti E:treatment:of:dysarthria</idno><idno type="wicri:Area/Main/Merge">001353</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:12-0026981</idno><idno type="wicri:Area/PascalFrancis/Corpus">000338</idno><idno type="wicri:Area/PascalFrancis/Curation">002976</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000342</idno><idno type="wicri:doubleKey">0885-3185:2011:Tripoliti E:treatment:of:dysarthria</idno><idno type="wicri:Area/Main/Merge">001932</idno><idno type="wicri:Area/Main/Curation">001300</idno><idno type="wicri:Area/Main/Exploration">001300</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease</title><author><name sortKey="Tripoliti, Elina" sort="Tripoliti, Elina" uniqKey="Tripoliti E" first="Elina" last="Tripoliti">Elina Tripoliti</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>UCL, Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Strong, Laura" sort="Strong, Laura" uniqKey="Strong L" first="Laura" last="Strong">Laura Strong</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>UCL, Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Hickey, Freya" sort="Hickey, Freya" uniqKey="Hickey F" first="Freya" last="Hickey">Freya Hickey</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>UCL, Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Foltynie, Tom" sort="Foltynie, Tom" uniqKey="Foltynie T" first="Tom" last="Foltynie">Tom Foltynie</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>UCL, Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Zrinzo, Ludvic" sort="Zrinzo, Ludvic" uniqKey="Zrinzo L" first="Ludvic" last="Zrinzo">Ludvic Zrinzo</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>UCL, Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Candelario, Joseph" sort="Candelario, Joseph" uniqKey="Candelario J" first="Joseph" last="Candelario">Joseph Candelario</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>UCL, Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Hariz, Marwan" sort="Hariz, Marwan" uniqKey="Hariz M" first="Marwan" last="Hariz">Marwan Hariz</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>UCL, Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Limousin, Patricia" sort="Limousin, Patricia" uniqKey="Limousin P" first="Patricia" last="Limousin">Patricia Limousin</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>UCL, Institute of Neurology, Sobell Department, Unit of Functional Neurosurgery, Queen Square, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-11">2011-11</date><biblScope unit="vol">26</biblScope><biblScope unit="issue">13</biblScope><biblScope unit="page" from="2434">2434</biblScope><biblScope unit="page" to="2436">2436</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">12A5E4E8257155C2B556028FF95ECCC9859A26B3</idno><idno type="DOI">10.1002/mds.23887</idno><idno type="ArticleID">MDS23887</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Deep Brain Stimulation (adverse effects)</term><term>Deep brain stimulation</term><term>Dysarthria</term><term>Dysarthria (etiology)</term><term>Dysarthria (physiopathology)</term><term>Dysarthria (therapy)</term><term>Humans</term><term>LSVT</term><term>Middle Aged</term><term>Nervous system diseases</term><term>Parkinson Disease (therapy)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>STN‐DBS</term><term>Severity of Illness Index</term><term>Speech</term><term>Speech Therapy (methods)</term><term>Subthalamic Nucleus (physiology)</term><term>Subthalamic Nucleus (surgery)</term><term>Subthalamic nucleus</term><term>Treatment</term><term>Treatment Outcome</term><term>speech</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Deep Brain Stimulation</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dysarthria</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Speech Therapy</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Subthalamic Nucleus</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Dysarthria</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Subthalamic Nucleus</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Dysarthria</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Middle Aged</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Dysarthrie</term><term>Maladie de Parkinson</term><term>Noyau sousthalamique</term><term>Parole</term><term>Pathologie du système nerveux</term><term>Stimulation cérébrale profonde</term><term>Traitement</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background:: Deep brain stimulation of the subthalamic nucleus (STN‐DBS) is an established treatment for patients with Parkinson's disease (PD). Speech impairment is a frequent side effect of the surgery. This study examined the efficacy of an intensive speech treatment, the Lee Silverman Voice Treatment (LSVT) on dysarthria after STN‐DBS. Methods:: The LSVT was administered to 10 patients with STN‐DBS (surgical group) and 10 patients without (medical group). Patients were assessed before, immediately after, and 6 months following the speech treatment using sustained phonation, a speech intelligibility scale, and monologue. Vocal loudness, speech intelligibility, and perceptual ratings were the primary outcome measures. Results:: Vocal loudness and perceptual scores improved significantly across tasks for the medical group only. Speech intelligibility did not significantly change for either group. Results in the surgical group were variable, with some patients deteriorating. Conclusions:: Treatment of dysarthria following STN‐DBS needs further investigation because of the variable response to LSVT. © 2011 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Tripoliti, Elina" sort="Tripoliti, Elina" uniqKey="Tripoliti E" first="Elina" last="Tripoliti">Elina Tripoliti</name></region><name sortKey="Candelario, Joseph" sort="Candelario, Joseph" uniqKey="Candelario J" first="Joseph" last="Candelario">Joseph Candelario</name><name sortKey="Foltynie, Tom" sort="Foltynie, Tom" uniqKey="Foltynie T" first="Tom" last="Foltynie">Tom Foltynie</name><name sortKey="Hariz, Marwan" sort="Hariz, Marwan" uniqKey="Hariz M" first="Marwan" last="Hariz">Marwan Hariz</name><name sortKey="Hickey, Freya" sort="Hickey, Freya" uniqKey="Hickey F" first="Freya" last="Hickey">Freya Hickey</name><name sortKey="Limousin, Patricia" sort="Limousin, Patricia" uniqKey="Limousin P" first="Patricia" last="Limousin">Patricia Limousin</name><name sortKey="Strong, Laura" sort="Strong, Laura" uniqKey="Strong L" first="Laura" last="Strong">Laura Strong</name><name sortKey="Zrinzo, Ludvic" sort="Zrinzo, Ludvic" uniqKey="Zrinzo L" first="Ludvic" last="Zrinzo">Ludvic Zrinzo</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001300 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001300 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:12A5E4E8257155C2B556028FF95ECCC9859A26B3
|texte= Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |